Invizyne Technologies Applies to Make Controlled Substances
Estimated reading time: 1–4 minutes
On December 1, 2025, the Drug Enforcement Administration (DEA) published a notice in the Federal Register about Invizyne Technologies, Inc. The notice says that Invizyne Technologies has applied to be a bulk manufacturer of a controlled substance.
Invizyne Technologies is based at 750 Royal Oaks Drive, Suite 106, Monrovia, California, 91016-6357. The company wants to make large amounts of a substance called Tetrahydrocannabinols. The drug code for Tetrahydrocannabinols is 7370. It belongs to Schedule I of controlled substances.
The company wants to make this substance as a synthetic version. They plan to use it either for making other materials inside their company or to sell it to their customers. This is the only activity allowed for this drug code under this registration.
People who are already registered to make bulk amounts of this kind of drug, and people who want to register, can send comments or objections to the DEA. They must do this by January 30, 2026. Anyone who wants to have a hearing about this application has to ask for it by January 30, 2026.
All comments need to be sent in electronically through the Federal eRulemaking Portal at https://www.regulations.gov. After sending a comment, people will get a Comment Tracking Number. The comment might not show up on the website right away.
The notice was signed by Thomas Prevoznik, Deputy Assistant Administrator at the DEA.
This notice is part of the government’s process to let the public know and ask for input when a company applies to make a controlled substance in bulk.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
